Pityriasis rosea is a common self-limited papulo-squamous disorder which accounts for about 2% of the patients in a dermatology practice. Although the disease can occur in every age group, it favors children and young adults. Females may be slightly more often affected. Characteristic is the occurrence of pityriasis rosea in clusters, more often in the spring and fall.


Topical Corticosteroid Lichen Planus Human Herpesvirus Seborrheic Dermatitis Tinea Corporis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen R. A., Janniger C. K., Schwartz R. A.: Pityriasis rosea. Cutis 56:198–202 (1995)PubMedGoogle Scholar
  2. Arndt K. A., Paul B.S., Stern R. S., Parrish J. A.: Treatment of pityriasis rosea with UV radiation. Archives of Dermatology 119:381–382 (1983)PubMedCrossRefGoogle Scholar
  3. Björnbcrg A., Hellgren L.: Pityriasis rosea. A statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Dermato-Venereologica 42(Supp150):1–68 (1962)Google Scholar
  4. Chuh A.A., Chiu S.S., Peiris J. S.: Human herpesvirus 6 and 7 in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study. Acta Derm Venereol 81:289–290 (2001)PubMedCrossRefGoogle Scholar
  5. Drago F., Ranieri E., Malaguti F., Losi E., Rebora A.: Human herpesvirus 7 in pityriasis rosea. Lancet 349: 1367–1368 (1997)PubMedCrossRefGoogle Scholar
  6. Karzon D. T., Hayner N. S., Winkelstein W. Jr., Barron A. L.: An epidemic of aseptic meningitis syndrome due to Echo virus type 6: a clinical study of Echo 6 infection. Pediatrics 29:418–431 (1962)PubMedGoogle Scholar
  7. Leenutaphong V., Jiamton S.: UVB phototherapy for pityriasis rosea: a bilateral comparison study. Journal of the American Academy of Derrnatology 33:996–999 (1995)CrossRefGoogle Scholar
  8. Leonforte J. F.: Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatology 163:480–481 (1980)CrossRefGoogle Scholar
  9. Rubins S., Ianniger C.K., Schwartz R.A.: Congenital and early acquired syphilis. Cutis 56:132–136 (1995)PubMedGoogle Scholar
  10. Sherma P. K., Yadav T. P., Gautam R. K., Taneja N., Satyanarayana L.: Erythromycin in pityriasis rosea: a double blind, placebo-controlled clinical trial. Journal of the American Academy of Dermatology 42:241–244 (2000)CrossRefGoogle Scholar
  11. Watanabe T., Kawamura T., Jacob S. E., Aquilino E. A., Orenstein J. M., Black J. B., Blauvelt A.: Pityriasis rosea is associated with systemic active infection with both hU111an herpesvirus-7 and human herpesvirus-6. J Invest Derrnatol 119:793–797 (2002)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • M. Möhrenschlager

There are no affiliations available

Personalised recommendations